Objetivo
Conduct Disorder (CD) and Oppositional Defiant Disorder with symptoms of Conduct Disorder (which is included among the abbreviation “CD” throughout the proposal) has a highly negative impact for the affected individual as well as for families and society. Although the number of females exhibiting serious aggressive behaviours is growing, the majority of studies on aetiology and treatment of CD have focused on male subjects only, despite strong evidence for a differential neurobiological basis of female CD. The key aims of the FemNAT-CD consortium are to identify biomarkers and to study disease mechanisms from pre- to postpubertal female CD as well as new psychological and pharmacological treatment options for female adolescent CD targeting emotion processing abilities. With the present proposal, we aim at clarifying the phenomenology and neurobiology of female CD from pre-puberty to post-puberty. We will study the role of genetic and environmental risk factors on female CD, related psychopathology, brain structure and function, HPA axis and autonomic nervous system (ANS) disturbance to elicit CD specific endophenotypes and its biomarkers. We will describe the clinical, neuronal and neurocognitive phenotype of female CD from pre- to postpuberty and related neuroendocrine and ANS function as well as moderating, mediating and direct risk factors to identify distinct homogeneous subtypes to guide targeted future treatment approaches. We translate knowledge of neuropsychological and neurobiological characteristics into targeted intervention by performing a randomised controlled trial of an innovative 16-week DBT-CD-A psychological treatment program focussing on emotion processing. The effect oxytocin and serotonin on neural function underlying emotion processing and aggression will be studied in a female animal model and two proof of concept pharmaco-challenge studies. We also target several societal and education objectives. Our consortium brings together strong clinical and basic science expertise on paediatric CD, including a number of SMEs and a professional management company.
Ámbito científico
Convocatoria de propuestas
FP7-HEALTH-2013-INNOVATION-1
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-FP - Small or medium-scale focused research projectCoordinador
60323 Frankfurt Am Main
Alemania
Ver en el mapa
Participantes (20)
52074 Aachen
Ver en el mapa
1081 HV Amsterdam
Ver en el mapa
SO17 1BJ Southampton
Ver en el mapa
4051 Basel
Ver en el mapa
69120 Heidelberg
Ver en el mapa
B15 2TT Birmingham
Ver en el mapa
La participación finalizó
D02 CX56 DUBLIN 2
Ver en el mapa
93053 Regensburg
Ver en el mapa
La participación finalizó
08221 TERRASSA
Ver en el mapa
48902 Barakaldo
Ver en el mapa
6720 Szeged
Ver en el mapa
10561 Athina
Ver en el mapa
La participación finalizó
82061 NEURIED
Ver en el mapa
89077 ULM
Ver en el mapa
54295 TRIER
Ver en el mapa
La participación finalizó
80333 Muenchen
Ver en el mapa
CF24 0DE Cardiff
Ver en el mapa
75008 Paris
Ver en el mapa
60438 Frankfurt
Ver en el mapa
1081 HV Amsterdam
Ver en el mapa